![]() |
Autobacs Seven Co., Ltd. (9832.T) Avaliação DCF
JP | Consumer Cyclical | Specialty Retail | JPX
|

- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Autobacs Seven Co., Ltd. (9832.T) Bundle
Simplifique a avaliação Autobacs Seven Co., Ltd. (9832T) com esta calculadora DCF personalizável! Apresentando o Real Autobacs Seven Co., Ltd. (9832T) e entradas de previsão ajustáveis, você pode testar cenários e descobrir o valor justo Autobacs Seven Co., Ltd. (9832T) em minutos.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 221,400.0 | 220,449.0 | 228,586.0 | 236,235.0 | 229,856.0 | 232,101.4 | 234,368.8 | 236,658.3 | 238,970.1 | 241,304.6 |
Revenue Growth, % | 0 | -0.42954 | 3.69 | 3.35 | -2.7 | 0.97688 | 0.97688 | 0.97688 | 0.97688 | 0.97688 |
EBITDA | 12,252.0 | 14,732.0 | 16,106.0 | 16,409.0 | 15,657.0 | 15,328.1 | 15,477.8 | 15,629.0 | 15,781.7 | 15,935.9 |
EBITDA, % | 5.53 | 6.68 | 7.05 | 6.95 | 6.81 | 6.6 | 6.6 | 6.6 | 6.6 | 6.6 |
Depreciation | 4,665.0 | 4,154.0 | 4,554.0 | 4,686.0 | 5,283.0 | 4,765.3 | 4,811.9 | 4,858.9 | 4,906.4 | 4,954.3 |
Depreciation, % | 2.11 | 1.88 | 1.99 | 1.98 | 2.3 | 2.05 | 2.05 | 2.05 | 2.05 | 2.05 |
EBIT | 7,587.0 | 10,578.0 | 11,552.0 | 11,723.0 | 10,374.0 | 10,562.7 | 10,665.9 | 10,770.1 | 10,875.3 | 10,981.6 |
EBIT, % | 3.43 | 4.8 | 5.05 | 4.96 | 4.51 | 4.55 | 4.55 | 4.55 | 4.55 | 4.55 |
Total Cash | 33,834.0 | 43,852.0 | 29,070.0 | 28,215.0 | 31,297.0 | 34,096.1 | 34,429.2 | 34,765.5 | 35,105.1 | 35,448.0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 46,467.0 | 28,402.0 | 30,058.0 | 29,711.0 | 26,233.0 | 32,963.4 | 33,285.4 | 33,610.5 | 33,938.9 | 34,270.4 |
Account Receivables, % | 20.99 | 12.88 | 13.15 | 12.58 | 11.41 | 14.2 | 14.2 | 14.2 | 14.2 | 14.2 |
Inventories | 20,774.0 | 18,327.0 | 21,516.0 | 23,899.0 | 22,635.0 | 21,851.5 | 22,065.0 | 22,280.5 | 22,498.2 | 22,718.0 |
Inventories, % | 9.38 | 8.31 | 9.41 | 10.12 | 9.85 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 |
Accounts Payable | 12,435.0 | 13,845.0 | 17,702.0 | 17,629.0 | 22,050.0 | 17,034.6 | 17,201.0 | 17,369.0 | 17,538.7 | 17,710.1 |
Accounts Payable, % | 5.62 | 6.28 | 7.74 | 7.46 | 9.59 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 |
Capital Expenditure | -3,429.0 | -3,996.0 | -6,300.0 | -7,182.0 | -9,149.0 | -6,098.7 | -6,158.3 | -6,218.4 | -6,279.2 | -6,340.5 |
Capital Expenditure, % | -1.55 | -1.81 | -2.76 | -3.04 | -3.98 | -2.63 | -2.63 | -2.63 | -2.63 | -2.63 |
Tax Rate, % | 38.2 | 38.2 | 38.2 | 38.2 | 38.2 | 38.2 | 38.2 | 38.2 | 38.2 | 38.2 |
EBITAT | 4,836.2 | 6,904.4 | 7,356.4 | 7,159.0 | 6,411.2 | 6,666.4 | 6,731.6 | 6,797.3 | 6,863.7 | 6,930.8 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -48,733.8 | 28,984.4 | 4,622.4 | 2,554.0 | 11,708.2 | -5,629.2 | 5,016.1 | 5,065.1 | 5,114.6 | 5,164.6 |
WACC, % | 5.65 | 5.66 | 5.65 | 5.64 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 |
PV UFCF | ||||||||||
SUM PV UFCF | 11,489.8 | |||||||||
Long Term Growth Rate, % | 1.00 | |||||||||
Free cash flow (T + 1) | 5,216 | |||||||||
Terminal Value | 112,181 | |||||||||
Present Terminal Value | 85,227 | |||||||||
Enterprise Value | 96,717 | |||||||||
Net Debt | -21,978 | |||||||||
Equity Value | 118,695 | |||||||||
Diluted Shares Outstanding, MM | 78 | |||||||||
Equity Value Per Share | 1,522.58 |
What You Will Receive
- Pre-Filled Financial Model: Autobacs Seven Co., Ltd.’s actual data allows for accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other critical variables.
- Instantaneous Calculations: Automatic updates provide immediate results as you make adjustments.
- Investor-Ready Template: A polished Excel file created for high-quality valuation presentations.
- Customizable and Reusable: Designed for adaptability, permitting repeated use for in-depth projections.
Key Features
- Pre-Loaded Data: Autobacs Seven Co., Ltd.'s historical financial statements and pre-populated forecasts.
- Fully Adjustable Inputs: Customize WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Instant Results: View Autobacs Seven Co., Ltd.'s intrinsic value recalculated in real time.
- Clear Visual Outputs: Dashboard charts illustrate valuation results and essential metrics.
- Built for Accuracy: A professional-grade tool designed for analysts, investors, and finance professionals.
How It Functions
- Download the Template: Gain immediate access to the Excel-based Autobacs Seven DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically recalculates Autobacs Seven's intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose Autobacs Seven Co., Ltd. (9832T)?
- Reliability: Backed by extensive industry experience and data integrity.
- Customization: Perfect for users looking to tailor their approach and inputs.
- Efficiency: Eliminate the complexities of starting from zero with your models.
- High Standards: Crafted with a focus on excellence suitable for top executives.
- Intuitive Design: Simple interface that’s accessible for all users, regardless of expertise.
Who Can Benefit from This Product?
- Automotive Investors: Create comprehensive and trustworthy valuation models for investment analysis in (9832T).
- Corporate Finance Departments: Evaluate valuation scenarios to inform strategic decisions within their organizations.
- Consultants and Financial Advisors: Deliver precise valuation insights for clients interested in (9832T).
- Students and Academics: Utilize real-world data to enhance financial modeling skills and education.
- Automotive Aficionados: Gain insights into how automotive companies like Autobacs Seven Co., Ltd. are assessed in the market.
Contents of the Template
- Historical Data: Features Autobacs Seven Co., Ltd.'s past financial performance and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates designed to assess the intrinsic value of Autobacs Seven Co., Ltd. (9832T).
- WACC Sheet: Built-in calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Customize essential variables such as growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: An extensive overview of Autobacs Seven Co., Ltd.'s financial data.
- Interactive Dashboard: Engage with valuation outcomes and forecasts through dynamic visualizations.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.